Combining immunotherapy and radiotherapy in hepatocellular carcinoma: the importance of irradiated tumor burden and the possible role of a low dose radiotherapy induction strategy

Transl Cancer Res. 2023 Apr 28;12(4):701-704. doi: 10.21037/tcr-23-192. Epub 2023 Apr 4.

Authors

Clemens Grassberger¹, Gentry King², Smith Apisarnthanarax¹

Affiliations

¹ Department of Radiation Oncology, University of Washington, Seattle, WA, USA.
² Fred Hutchinson Cancer Research Center, University of Washington School of Medicine, Seattle, WA, USA.

No abstract available

Keywords: Hepatocellular carcinoma (HCC); checkpoint inhibition; combination therapy; radiotherapy (RT); tumor burden.

Publication types

Editorial
Comment